These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 30374356)
1. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression. Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E Front Immunol; 2018; 9():2360. PubMed ID: 30374356 [TBL] [Abstract][Full Text] [Related]
2. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276 [TBL] [Abstract][Full Text] [Related]
3. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577 [TBL] [Abstract][Full Text] [Related]
4. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals. Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796 [TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56 Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K Front Immunol; 2021; 12():640672. PubMed ID: 34017328 [TBL] [Abstract][Full Text] [Related]
6. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145 [TBL] [Abstract][Full Text] [Related]
7. The biology of human natural killer-cell subsets. Cooper MA; Fehniger TA; Caligiuri MA Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225 [TBL] [Abstract][Full Text] [Related]
8. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. Chan A; Hong DL; Atzberger A; Kollnberger S; Filer AD; Buckley CD; McMichael A; Enver T; Bowness P J Immunol; 2007 Jul; 179(1):89-94. PubMed ID: 17579025 [TBL] [Abstract][Full Text] [Related]
9. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
12. Human CD56bright NK Cells: An Update. Michel T; Poli A; Cuapio A; Briquemont B; Iserentant G; Ollert M; Zimmer J J Immunol; 2016 Apr; 196(7):2923-31. PubMed ID: 26994304 [TBL] [Abstract][Full Text] [Related]
13. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217 [TBL] [Abstract][Full Text] [Related]
14. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534 [TBL] [Abstract][Full Text] [Related]
15. Human CD56 Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J Front Immunol; 2017; 8():699. PubMed ID: 28674534 [TBL] [Abstract][Full Text] [Related]
16. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859 [TBL] [Abstract][Full Text] [Related]
17. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets. Eidukaite A; Siaurys A; Tamosiunas V Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821 [TBL] [Abstract][Full Text] [Related]
19. Ascorbic Acid Promotes Wu CY; Zhang B; Kim H; Anderson SK; Miller JS; Cichocki F J Immunol; 2020 Sep; 205(6):1513-1523. PubMed ID: 32759296 [TBL] [Abstract][Full Text] [Related]